
Viveve Medical VIVE
Quarterly report 2022-Q3
added 11-10-2022
Viveve Medical Interest Expense 2011-2026 | VIVE
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Viveve Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 M | 910 K | 4.35 M | 4.37 M | 3.17 M | 1.37 M | 415 K | 567 K | 447 K | 555 K | 396 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.37 M | 396 K | 1.6 M |
Quarterly Interest Expense Viveve Medical
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 292 K | 284 K | 270 K | - | 255 K | 245 K | 234 K | - | 235 K | 223 K | 210 K | - | 1.21 M | 1.19 M | 1.12 M | - | 1.11 M | 1.06 M | 1.07 M | - | 777 K | 1.34 M | 263 K | - | 221 K | 765 K | 108 K | - | 114 K | 105 K | 83 K | - | 152 K | 71 K | 176 K | - | 157 K | 61 K | 140 K | - | 137 K | 116 K | 116 K | - | 116 K | 115 K | 46 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.34 M | 46 K | 394 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
AxoGen
AXGN
|
167 K | $ 28.6 | -1.92 % | $ 1.32 B | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 12.19 | -3.02 % | $ 1.83 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 36.62 | -4.9 % | $ 5.46 K | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 8.63 | 2.92 % | $ 620 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 9.51 | -0.94 % | $ 1.29 B | ||
|
Electromed
ELMD
|
78 K | $ 24.0 | -1.56 % | $ 203 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 40.21 | -2.9 % | $ 1.25 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.21 | -0.94 % | $ 157 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.16 | -3.07 % | $ 109 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.48 | -0.48 % | $ 121 M | ||
|
Accuray Incorporated
ARAY
|
559 K | $ 0.49 | -2.39 % | $ 50.4 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 173.34 | -1.29 % | $ 13 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 3.65 | -2.93 % | $ 773 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
548 M | $ 109.92 | -0.95 % | $ 191 B | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 98.53 | -1.57 % | $ 1.25 B | ||
|
Inogen
INGN
|
2.44 M | $ 6.46 | -1.37 % | $ 172 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 71.46 | -2.09 % | $ 106 B | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 18.05 | 1.29 % | $ 423 M | ||
|
Pulmonx Corporation
LUNG
|
256 K | $ 2.03 | 25.78 % | $ 79.4 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.17 | -3.55 % | $ 1.32 M | ||
|
Medtronic PLC
MDT
|
402 M | $ 90.96 | -2.2 % | $ 117 B | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 82.03 | -2.21 % | $ 48 B |